First Ever Investigational 18F-CD8 PET Radiopharmaceutical Aims to Predict and Monitor Early Response to Cancer Immunotherapies
CHALFONT ST. GILES, England--(BUSINESS WIRE)--With immunotherapy emerging as one of the most important treatment options in oncology, GE HealthCare has today announced the first patient scanned......
